» Articles » PMID: 14972550

Identification of Murine T-cell Epitopes in Ebola Virus Nucleoprotein

Overview
Journal Virology
Specialty Microbiology
Date 2004 Feb 20
PMID 14972550
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

CD8 T cells play an important role in controlling Ebola infection and in mediating vaccine-induced protective immunity, yet little is known about antigenic targets in Ebola that are recognized by CD8 T cells. Overlapping peptides were used to identify major histocompatibility complex class I-restricted epitopes in mice immunized with vectors encoding Ebola nucleoprotein (NP). CD8 T-cell responses were mapped to a H-2(d)-restricted epitope (NP279-288) and two H-2(b)-restricted epitopes (NP44-52 and NP288-296). The identification of these epitopes will facilitate studies of immune correlates of protection and the evaluation of vaccine strategies in murine models of Ebola infection.

Citing Articles

Protective CD8+ T Cell Response Induced by Modified Vaccinia Virus Ankara Delivering Ebola Virus Nucleoprotein.

Kupke A, Volz A, Dietzel E, Freudenstein A, Schmidt J, Shams-Eldin H Vaccines (Basel). 2022; 10(4).

PMID: 35455282 PMC: 9027530. DOI: 10.3390/vaccines10040533.


Structural and Functional Aspects of Ebola Virus Proteins.

Jain S, Martynova E, Rizvanov A, Khaiboullina S, Baranwal M Pathogens. 2021; 10(10).

PMID: 34684279 PMC: 8538763. DOI: 10.3390/pathogens10101330.


Characterization of Antigenic MHC-Class-I-Restricted T Cell Epitopes in the Glycoprotein of Ebolavirus.

Powlson J, Wright D, Zeltina A, Giza M, Nielsen M, Rampling T Cell Rep. 2019; 29(9):2537-2545.e3.

PMID: 31775024 PMC: 6899439. DOI: 10.1016/j.celrep.2019.10.105.


Conserved peptide vaccine candidates containing multiple Ebola nucleoprotein epitopes display interactions with diverse HLA molecules.

Jain S, Baranwal M Med Microbiol Immunol. 2019; 208(2):227-238.

PMID: 30790057 DOI: 10.1007/s00430-019-00584-y.


T-Cell Response to Viral Hemorrhagic Fevers.

Perdomo-Celis F, Salvato M, Medina-Moreno S, Zapata J Vaccines (Basel). 2019; 7(1).

PMID: 30678246 PMC: 6466054. DOI: 10.3390/vaccines7010011.